These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36600874)

  • 1. Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance.
    Rafaey W; Munir Alvi A; Siddiqi AI; Shafiq W; Irfan H
    Cureus; 2022 Nov; 14(11):e32088. PubMed ID: 36600874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
    Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
    BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermixed medullary and papillary thyroid cancer in a patient with renal cell carcinoma.
    Samarasinghe S; Yuksel S; Mehrotra S
    Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32538376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanotic medullary thyroid carcinoma: A case report with review of the literature.
    Brzezinska KA; Bhardwaj S; Teng MS; Si Q; Sun J; Westra WH; Zakowski MF; Szporn AH
    Diagn Cytopathol; 2023 Jan; 51(1):E14-E20. PubMed ID: 36056712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
    Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
    Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant medullary thyroid carcinoma with paraganglioma-like pattern and papillary thyroid carcinoma.
    Greco C; Brigante G; Taliani E; Corrado S; Simoni M; Madeo B
    Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31778356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering the Uncommon: An 81-Year-Old Woman With Elevated Carcinoembryonic Antigen (CEA) but Normal Calcitonin Levels Diagnosed With Medullary Thyroid Carcinoma.
    Ukrani J; Barnes M; Ashraf A; Haggerty G; Dacosta N
    Cureus; 2023 Jun; 15(6):e40290. PubMed ID: 37448402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.
    Liu Y; Yuan L; Yang D; Jin Y
    Diagn Cytopathol; 2018 Aug; 46(8):690-693. PubMed ID: 29524315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
    Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
    Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
    Murphy DC; Johnson SJ; Aspinall S
    Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary Thyroid Carcinoma: A Unique Case Report.
    A S; Priya Asokan L; Kani V; Harikrishnan V
    Cureus; 2024 Jul; 16(7):e64969. PubMed ID: 39161494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
    Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
    BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.
    Alapat DV; Ain KB; Sloan DA; Monaghan KG; Karabakhtsian RG
    Endocrine; 2011 Apr; 39(2):148-52. PubMed ID: 21243446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
    Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
    Chen SW; Chen YK
    World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medullary thyroid cancer with undetectable serum calcitonin.
    Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
    J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Malignant Duo: Mixed Medullary and Follicular Variant Papillary Thyroid Cancer.
    Alshaakh Mohd Mari A; Titus J; Zayat V; Kinaan M
    Cureus; 2024 Aug; 16(8):e67231. PubMed ID: 39295705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy.
    Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
    Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.